Nikhil Munshi's guest appearances

Nikhil Munshi

The Hematologist

Ken Anderson

Rachel Yehuda

David Anderson

Stephanie Lee

George Daley

Hassan Murad

Ariela Marshall

John Gribben

Steven Horwitz

Melody Smith

Eytan Stein

Stella Chou

Michael Linenberger

Stephan Moll

Ashok Pai

OwlTail

Saad Usmani

In this podcast, Contributing Editor Dr. Saad Usmani has a conversation with Dr. Nikhil Munshi. They discuss Dr. Usmani’s Mini Review article from the July/August 2021 issue of The Hematologist, titled, "Immune Therapies for Myeloma: The CARs Are Here but What’s Next?" They discuss the latest approvals of chimeric antigen receptor T-cell therapies to treat multiple myeloma. You can access his Mini Review article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.4.2021413/476193/Immune-Therapies-for-Myeloma-The-CARs-Are-Here-but?utm_source=sfmc&amp;utm_medium=email&amp;utm_campaign=TheHem+July+2021&amp;utm_term=Link+Text+%c2%bb&amp;utm_id=102625&amp;sfmc_id=3....Additional ASH affiliation and COI information: Dr. Usmani has received research funding from Amgen, Array Biopharma, BMS, Celgene, GSK, Janssen, Merck, Pharmacyclics, Sanofi, Seattle Genetics, SkylineDX, and Takeda; consulting fees from Amgen, BMS, Celgene, EdoPharma, GSK, Janssen, Sanofi, Seattle Genetics, SecuraBio, SkylineDX, Takeda, and TeneoBio; speaker fees from Amgen, BMS, Janssen, and Sanofi.Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In this podcast, Contributing Editor Dr. Saad Usmani has a conversation with Dr. Nikhil Munshi. They discuss Dr. Usmani’s Mini Review article from the July/August 2021 issue of The Hematologist, titled, "Immune Therapies for Myeloma: The CARs Are Here but What’s Next?" They discuss the latest approvals of chimeric antigen receptor T-cell therapies to treat multiple myeloma. You can access his Mini Review article online at <a href="https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.4.2021413/476193/Immune-Therapies-for-Myeloma-The-CARs-Are-Here-but?utm_source=sfmc&amp;utm_medium=email&amp;utm_campaign=TheHem+July+2021&amp;utm_term=Link+Text+%c2%bb&amp;utm_id=102625&amp;sfmc_id=32555314" rel="nofollow" target="_blank">https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.4.2021413/476193/Immune-Therapies-for-Myeloma-The-CARs-Are-Here-but?utm_source=sfmc&amp;utm_medium=email&amp;utm_campaign=TheHem+July+2021&amp;utm_term=Link+Text+%c2%bb&amp;utm_id=102625&amp;sfmc_id=3...</a>.<br>Additional ASH affiliation and COI information: Dr. Usmani has received research funding from Amgen, Array Biopharma, BMS, Celgene, GSK, Janssen, Merck, Pharmacyclics, Sanofi, Seattle Genetics, SkylineDX, and Takeda; consulting fees from Amgen, BMS, Celgene, EdoPharma, GSK, Janssen, Sanofi, Seattle Genetics, SecuraBio, SkylineDX, Takeda, and TeneoBio; speaker fees from Amgen, BMS, Janssen, and Sanofi.<br>Music: “Jellyfish in Space” Kevin MacLeod (<a href="http://incompetech.com" rel="nofollow" target="_blank">incompetech.com</a>). Licensed under Creative Commons: By Attribution 3.0 <a href="http://creativecommons.org/licenses/by/3.0/" rel="nofollow" target="_blank">creativecommons.org/licenses/by/3.0/</a>

Immune Therapies for Myeloma, With Drs. Saad Usmani and Nikhil Munshi